Phase 1 Metastatic Pancreatic Ductal Adenocarcinoma trials recruiting now
All Metastatic Pancreatic Ductal Adenocarcinoma trials, every phase
7
Phase 1 recruiting
Other phases for Metastatic Pancreatic Ductal Adenocarcinoma
Phase 1 Metastatic Pancreatic Ductal Adenocarcinoma trials
- BBO-11818 in Adult Subjects With KRAS Mutant Cancer
- MK2 Inhibitor in Combination With mFOLFIRINOX for Untreated Metastatic Pancreatic Ductal Adenocarcinoma
- ONT01 and Gemcitabine/Nab-paclitaxel as Second Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma
- Pegcetacoplan in Combination With Modified FOLFIRINOX for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma
- SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells
- Study of JAB-23E73 in Combination With Chemotherapy in Participants With Metastatic PDAC Harboring KRAS Gene Alterations
- Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Common questions
What does Phase 1 mean?
Is this list complete?
No. For the full record, search ClinicalTrials.gov.